Hong-Yuan Chu, PhD, received his PhD degree in neuropharmacology from the Shanghai Institute of Materia Medica (China) in 2010. He then relocated to the United States to conduct postdoctoral research with positions at the National Institute of Mental Health (Bethesda, MD) and the Department of Physiology and Udall Center of Excellence in Parkinson’s Disease Research at Northwestern University (Chicago, IL). In 2019, Dr. Chu was recruited to the Department of Neurodegenerative Science at the Van Andel Institute (Grand Rapids, MI), where he is currently an assistant professor. His laboratory uses multiple technologies to understand how progressive dopaminergic neurodegeneration alters the connectivity and function of cortico-basal ganglia-thalamocortical circuits and how such changes contribute to the motor deficits in Parkinson’s disease. Dr. Chu holds an R01 research award from the National Institutes of Health and the NARSAD Young Investigator Award from the Brain & Behavior Research Foundation (2020).